- Investing.com
Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Metrics to compare | NAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNANPeersSector | |
---|---|---|---|---|
P/E Ratio | 83.2x | −3.5x | −0.4x | |
PEG Ratio | 19.43 | −0.04 | 0.00 | |
Price/Book | 7.3x | 2.7x | 2.6x | |
Price / LTM Sales | 7.5x | 2.6x | 2.9x | |
Upside (Analyst Target) | 0.2% | 203.6% | 54.4% | |
Fair Value Upside | Unlock | 12.3% | 9.3% | Unlock |